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In vitro characterization of Multivalent Adhesion
Molecule 7-based inhibition of multidrug-resistant
bacteria isolated from wounded military personnel
Anne Marie Krachler,1 Katrin Mende,2,3 Clinton Murray3 and Kim Orth1,*
1Department of Molecular Biology; UT Southwestern Medical Center; Dallas, TX USA; 2Infectious Disease Clinical Research Program; Uniformed Services University of the Health Sciences;
Bethesda, MD USA; 3Infectious Disease Service; San Antonio Military Medical Center; Fort Sam Houston, TX USA
Keywords: wound infections, multidrug-resistance, anti-adhesion treatment, adhesin, bacterial attachment, MAM7, Pseudomonas,
Klebsiella, Acinetobacter
Abbreviations: MAM, Multivalent Adhesion Molecule; MRSA, methicillin-resistant Staphylococcus aureus; ABC, Acinetobacter
baumannii-calcoaceticus complex; ESBL, extended spectrum β-lactamase; EPEC, enteropathogenic Escherichia coli;
MDR, multidrug-resistant; MOI, multiplicity of infection
Treatment of wounded military personnel at military medical centers is often complicated by colonization and infection
of wounds with pathogenic bacteria. These include nosocomially transmitted, often multidrug-resistant pathogens such
as Acinetobacter baumannii-calcoaceticus complex, Pseudomonas aeruginosa and extended spectrum b-lactamase-
producing Escherichia coli and Klebsiella pneumoniae. We analyzed the efficacy of Multivalent Adhesion Molecule (MAM)
7-based anti-adhesion treatment of host cells against aforementioned pathogens in a tissue culture infection model.
Herein, we observed that a correlation between two important hallmarks of virulence, attachment and cytotoxicity, could
serve as a useful predictor for the success of MAM7-based inhibition against bacterial infections. Initially, we
characterized 20 patient isolates (five from each pathogen mentioned above) in terms of genotypic diversity,
antimicrobial susceptibility and important hallmarks of pathogenicity (biofilm formation, attachment to and cytotoxicity
toward cultured host cells). All isolates displayed a high degree of genotypic diversity, which was also reflected by large
strain-to-strain variability in terms of biofilm formation, attachment and cytotoxicity within each group of pathogen.
Using non-pathogenic bacteria expressing MAM7 or latex beads coated with recombinant MAM7 for anti-adhesion
treatment, we showed a decrease in cytotoxicity, indicating that MAM7 has potential as a prophylactic agent to attenuate
infection by multidrug-resistant bacterial pathogens.
Introduction
Wound treatment and healing is often complicated by coloniza-
tion and infection of wounds with bacterial pathogens.
Colonization screening at time of admission performed on
military medical personnel wounded in combat during missions
in Iraq and Afghanistan has shown that the majority of wound
infections are caused by a limited number of bacterial species.1
Besides Gram-positive methicillin-resistant Staphylococcus aureus
(MRSA), there are a number of Gram-negative bacteria routinely
isolated from wounds, including Acinetobacter baumannii-calcoa-
ceticus complex (ABC), Pseudomonas aeruginosa and extended
spectrum β-lactamase (ESBL)-producing Enterobacteriacea such
as Escherichia coli and Klebsiella pneumoniae. Together, these are
the causal agents of a large proportion of wound-associated
infections, which are responsible for prolonged wound healing,
thereby leading to extended periods of care.2-5 Screening
performed over a period of 2003–2009 revealed that an increasing
number of isolates could be classified as multidrug-resistant
(MDR), additionally complicating the care and treatment of
infected patients.1,6,7 Attempts have been made to prevent
infection by administering antimicrobials in the field, but this
has only lead to limited success.8 Thus, there is a clear need for
alternative approaches to prevent infections or treat existing
infections.
We have recently identified a novel group of adhesins, termed
Multivalent Adhesion Molecule (MAM) 7, which is widely found
in Gram-negative pathogens. These adhesins are constitutively
expressed and involved in initial attachment of pathogens to host
cells, by interacting with both the host cell receptor phosphatidic
acid and the co-receptor fibronectin.9,10 We have previously
explored the use of non-pathogenic bacteria expressing MAM7 on
their surface (BL21-MAM7) or recombinant, purified MAM7
immobilized on polymer beads (bead-MAM7), which mimics the
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bacterial surface display of the adhesin, as a way of inhibiting
bacterial attachment.9,11 Pre-treatment of host cells with MAM7-
based inhibitors has proved to be effective in ameliorating the
effects of bacterial infection with a range of important clinical
pathogens, including Vibrio parahemolyticus, Vibrio cholerae,
Yersinia pseudotuberculosis and enteropathogenic E. coli (EPEC).
In the present study, we set out to explore the potential of
MAM7-based inhibitors against infection with patient-derived
bacterial isolates associated with hard-to-treat wound infections,
since MAM7 homologs have been identified in sequenced strains
from all five bacterial species used. We further compared the
susceptibilities of the bacterial isolates to conventional antimicro-
bials with their susceptibility to MAM7-based inhibition in vitro.
Lastly, we characterized several features described to contribute to
pathogenicity, such as biofilm formation, host cell attachment and
cytotoxicity toward host cells, caused by each of the isolates. Based
on our findings, we propose that isolates that show a correlation
between their ability to attach to host cells and to cause
cytotoxicity are generally more susceptible to MAM7-based anti-
adhesion treatment. However, this hypothesis is based on a
limited set of isolates tested and our studies will have to be
extended to include a larger variety of bacterial strains to be
tested further.
Results
Isolation and genotyping of bacterial strains associated with
patient wounds. Bacterial isolates were collected from infected
patients treated at the San Antonio Military Medical Center at
Fort Sam Houston, Texas, following their evacuation from
Afghanistan and Iraq, during a time period spanning the years
2006 to 2010.12,13 We characterized a total of 20 different isolates
obtained either by superficial (three cases) or deep wound culture
(14 cases), blood culture (two cases) or urine culture (one case),
each of which belonged to one of the four most predominant
species of Gram-negative bacteria leading to wound infections,
ABC, P. aeruginosa and ESBL-producing K. pneumoniae and
E. coli (each represented by five isolates, respectively). Pulsed field
gel electrophoresis (PFGE) was used for genotypic characteriza-
tion of all isolates and revealed a high degree of genotypic diversity
within each of the four groups, with each of the five isolates
within each group representing a distinct genotype (Table 1).
Clinical isolates from patient wounds vary in their ability
to form biofilms, attach to host cells and cause cytotoxicity.
Next, we studied the bacterial isolates for their ability to form
biofilms and attach to cultured HeLa epithelial cells and 3T3
fibroblasts using serial dilution plating assays. K. pneumoniae and
Table 1. Details of isolation, genotyping and phenotypic characterization of bacterial isolates
Species Isolate No. Year of isolation Source PFGE type Biofilm formation (%) Hemolysis
ABC
1 2006 Blood ABC PFT 4 31 N
2 2006 Blood ABC PFT 3 109 N
3 2007 Wound culture superficial ABC PFT 1 222 N
4 2007 Wound culture deep ABC PFT 2 38 N
5 2008 Wound culture deep ABC PFT 5 55 N
P. aeruginosa
1 2008 Wound culture deep PA PFT 7 62 N
2 2007 Wound culture deep PA PFT 2 192 N
3 2009 Wound culture deep PA PFT 1 183 N
4 2007 Wound culture deep PA PFT 4 149 N
5 2008 Wound culture superficial PA PFT 5 182 N
K. pneumoniae
1 2007 Wound culture deep KP PFT 1 420 N
2 2008 Wound culture deep KP PFT 2 132 N
3 2009 Wound culture deep KP PFT 7 129 N
4 2007 Wound culture deep KP PFT 3 58 N
5 2008 Wound culture deep KP PFT 9 246 N
E. coli
1 2007 Wound culture deep EC PFT 3 24 N
2 2007 Wound culture superficial EC PFT 4 20 N
3 2009 Wound culture deep EC PFT 1 20 N
4 2010 Wound culture deep EC PFT 7 25 N
5 2008 Urine culture EC PFT 2 180 N
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P. aeruginosa isolates showed the greatest tendency to form
biofilms (197 ± 142% and 154 ± 54%, respectively), followed by
ABC (105 ± 77%) and E. coli (54 ± 71%) (Table 1). In contrast,
ABC isolates had the greatest ability to attach to host cells,
followed by K. pneumoniae, P. aeruginosa and E. coli (Fig. 1A–D).
However, we observed a large variability in attachment properties
within each group, with E. coli isolates showing the most
variability (attachment ranged from 15% for isolate #2 to 73% for
isolate #5). In addition, we tested all 20 isolates for their ability to
cause cytotoxicity in host cells within a 4 h infection experiment
using lactate dehydrogenase (LDH) release assays. ABC isolates
caused the highest overall cytotoxicity, followed by P. aeruginosa,
K. pneumoniae and E. coli (Fig. 1E–H). The variability was largest
among the K. pneumonia isolates, with cell lysis ranging from 24%
for isolate #2 to 69% for isolate #3. Moreover, we noted two
interesting features when comparing attachment and cytotoxicity
profiles of the tested isolates. First, in most cases the strains
showed a slightly higher attachment and cytotoxic effect on 3T3
fibroblasts. Second, in the case of all groups of pathogens except
P. aeruginosa, we observed positive correlation between host cell
attachment and pathogen-induced cytotoxicity (Fig. 1I–L).
Isolates display a high degree of resistance against a wide
range of commonly used antimicrobials. One of the greatest
problems faced in treatment of Gram-negative wound infections
is the increasing number of MDR bacterial isolates found in
patients. We performed antimicrobial susceptibility testing (AST)
by determining the minimal inhibiting concentration (MIC) of a
panel of antimicrobials on all 20 bacterial isolates using the BD
Figure 1. Host cell attachment and lysis by bacterial isolates. Attachment (top) and cell lysis (LDH release), (middle) caused by five different isolates each
of ABC (A and E), P. aeruginosa (B and F), K. pneumoniae (C and G) and E. coli (D and H) tested on HeLa (blue) and 3T3 (red) cells. Values given are
means ± standard error (n = 3) from a representative experiment performed in triplicate. Correlation between attachment and cytotoxicity on HeLa (●)
and 3T3 (○) cells across different isolates (I–L). Pearson correlation coefficients (r-values) and significance levels for correlation coefficients (p-values) were
used to analyze the correlation between strain attachment and cytotoxicity.
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PhoenixTM Automated Microbiology System (Becton Dickinson;
Table 2). Antimicrobial panels included several drugs from each
of the four most commonly used classes of antimicrobials,
aminoglycosides, β-lactams, carbapenems and fluoroquinolones.
The panels also included antimicrobials from other classes, such as
trimethoprim/sulfamethoxazole, but resistance to these was not
considered in the classification of isolates as MDR.7 All tested
ABC and P. aeruginosa isolates were found to be MDR. According
to the CDC definition, all isolates of ESBL-producing
K. pneumoniae and E. coli are also considered MDR. The
K. pneumoniae and E. coli we tested indeed displayed a high
degree of resistance, being non-susceptible to most aminoglyco-
sides, β-lactams and fluoroquinolones tested (Table 2). All
K. pneumoniae and E. coli isolates were susceptible to the tested
carbapenems (imipenem, meropenem and ertapenem).
Prophylactic anti-adhesion treatment decreases pathogen-
mediated cytotoxicity for a large number of clinical isolates. We
have previously demonstrated that a widely conserved adhesin
found in Gram-negative bacteria, termed Multivalent Adhesion
Molecule (MAM) 7 can be used to block bacterial attachment
sites on host cells, thus diminishing infection by gastrointestinal
pathogens such as Vibrio parahemolyticus, Vibrio cholerae, Yersinia
pseudotuberculosis and EPEC in tissue culture models of infection.9
Herein, we investigated if such treatment could be successfully
extended to include relevant wound-associated pathogens and
tested if MAM7-based anti-adhesion treatment would affect the
cytotoxicity mediated by the clinical isolates on HeLa or 3T3 cells
using LDH release assays. We used MAM7 either expressed
on the surface of non-pathogenic E. coli (BL21-MAM7) or
recombinant, purified MAM7 protein immobilized on 1mm latex
beads to mimic surface display on bacteria (bead-MAM7).
Cultured cells were pre-incubated with BL21-MAM7 at a
multiplicity of infection (MOI) of 100 or bead-MAM7 at a
dosage of 7.5 mg protein/106 beads/well for 30 min. Excess
inhibitor was subsequently removed by washing and cells were
infected with each of the 20 isolates at an MOI of 10.
Cytotoxicity toward HeLa and 3T3 cells, either without pre-
incubation or following anti-adhesion treatment with BL21-
MAM7 or MAM7-beads, was assessed following 4 h of infection
(Figs. 2 and 3, respectively). Overall, we observed a large decrease
in cytotoxicity when cells were pre-incubated with MAM7-based
inhibitors, with the extent of inhibition mediated by either
BL21-MAM7 or MAM7-beads being very similar. We have
previously shown that pre-incubation with either GST-beads or
BL21MAM7DN1–44 does not ameliorate the effects of subsequent
bacterial infections.9,11 The highest protective effect toward HeLa
cells was observed with treatment against ABC (mean inhibition
of 76 ± 8% with BL21-MAM7 and 68 ± 6% with MAM7-beads)
and K. pneumoniae isolates (mean inhibition of 85 ± 4% and 71 ±
18% with BL21 and beads, respectively) (Fig. 2A and C). In
contrast, the inhibitory effect against P. aeruginosa (48 ± 30% and
43 ± 24% for bacteria and beads, respectively) and E. coli (54 ±
19%/51 ± 20%) was less pronounced for most strains, but the
variability of treatment responses between different isolates within
these groups was generally high (Fig. 2B and D). For example
in the case of P. aeruginosa, cytotoxicity inhibition ranged from
. 91% for isolate #1 to 12% for isolate #3. The inhibitory
profiles were very similar between HeLa cells and 3T3 cells
(Fig. 3).
Visualization of MAM7 inhibitory potential on bacterial
infections using confocal microscopy. To visualize the detri-
mental effects of individual pathogens as well as the protective
potential of MAM7 inhibitors, we chose representative strains
from each of the four groups (marked with arrow in Figs. 2
and 3) and analyzed infections of both HeLa and 3T3 cells as well
as inhibition experiments using confocal microscopy (Figs. 4
and 5). This allowed us to further test and correlate results found
in LDH release assays with cellular phenotypes. For this purpose,
cells were infected with either ABC #1, P. aeruginosa #1,
K. pneumoniae #1 or E. coli #5 (all of which showed good
responses to anti-adhesion treatment with MAM7). In addition,
we analyzed infections with P. aeruginosa #3, which showed the
lowest response to inhibition. Comparative microscopic analyses
of HeLa cells infected with either P. aeruginosa isolate #1 or #3
demonstrated a large difference between cellular phenotypes
following infection with the two isolates, which is in agreement
with our findings from LDH release experiments as well as PFGE
analyses. While infection with P. aeruginosa #1 caused only
limited cell rounding and lysis, even after several hours of
infection, and was predominated by an actin phenotype
characterized by induction of filopodia and microspikes, isolate
#3 causes rapid cell rounding and cell lysis with seemingly no
intermediate phenotype (Fig. 4C and D). ABC #1 and E. coli #5
both caused rapid cell rounding (Fig. 4B and F), while
K. pneumoniae #1 caused slower and limited rounding and lead
to formation of actin protrusions which were distinct from those
observed with P. aeruginosa isolate #1 (Fig. 4E). With 3T3 cells, it
was harder to discern distinct phenotypes of infection, since upon
infection with most bacterial isolates the 3T3 cells underwent
rapid deterioration characterized by formation of actin stress fibers
and microspikes, followed by cell lysis (Fig. 5). However, with
both HeLa and 3T3 cells, pre-incubation with BL21-MAM7 and
MAM7-beads markedly slowed down the progress of infection,
with only limited cell rounding and lysis visible after infection
with either ABC #1, P. aeruginosa #1, K. pneumoniae #1 or E. coli
#5. In all these cases, the remaining cellular phenotypes were
limited to changes in actin phenotype, such as formation of stress
fibers, filopodia or microspikes (Figs. 4 and 5H–R). In contrast,
cellular phenotypes following infection with P. aeruginosa isolate
#3 did not change upon pre-treatment with either BL21-MAM7
or MAM7-beads on either cell type (Figs. 4 and 5J and P), which
is also in agreement with our results from LDH assays.
Discussion
Bacterial colonization and infection of wounds is a common cause
of complication of treatment in military personnel receiving care
at military medical facilities following evacuation from combat
sites. Wound-associated infections with Gram-negative bacteria
are predominantly caused by ABC, P. aeruginosa and ESBL-
producing E. coli and K. pneumonia.1 The increasing number of
MDR pathogens isolated from patients poses a serious concern
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and underpins the necessity for alternative measures in infection
prophylaxis and therapy. Anti-adhesion treatment has been
considered and tested as an alternative to small molecule
antimicrobials. In most cases, this is based on administering
molecular mimics of host cell receptor structures, such as sugars or
sugar mimics.14-17 Following our previous studies exploring the
use of MAM7-based inhibitors in anti-adhesion prophylaxis of
bacterial infections with gastrointestinal pathogens, we set out to
explore the potential of these inhibitory molecules against
infection with wound-associated Gram-negative pathogens.
We utilized five representative patient isolates from each of the
five above-mentioned Gram-negative bacterial species. We chose a
range of phenotypically diverse isolates to ensure our sampling
would be representative and our findings would be generally
applicable for outbreak strains. PFGE typing showed that all
isolates were genotypically distinct. Although this is in part due to
a conscious choice of isolates displaying a high degree of
phenotypic diversity upon initial characterization (biofilm
formation, colony morphology on culture media), which is also
reflected in their genotypic diversity, it also reflects the fact that
outbreaks are not clonal.
A major problem in the treatment of wound-associated
infections is the increasing number of MDR organisms
encountered. Admission-associated screening over the period of
2003–2009 has revealed that a wide range of patient isolates are
resistant against most antimicrobials commonly used in the clinic
and their ability to rapidly acquire additional resistance, such as
described in the case of ABC isolates, which developed colistin
resistance during the period of testing.1,18 This trend was also
confirmed in the present study—all tested isolates have to be
considered MDR.
We further analyzed a range of parameters described to be
important contributing factors for virulence, using in vitro and
tissue culture assays. These included biofilm formation, attach-
ment to host cells and cytotoxicity in tissue culture models of
infection.19-22 The majority of strains (64%) were found to form
biofilms in vitro and all strains displayed an ability to attach to
host cells and elucidate host cell killing. However, the degree of
attachment and cytotoxicity varied widely across all tested isolates
as well as between isolates within the same species, which is in
agreement with the genotypic variance found during PFGE
profiling of the isolates.
Figure 2. Anti-adhesion treatment of HeLa cells infected with bacterial
isolates. Cytotoxocity of ABC (A), P. aeruginosa (B), K. pneumoniae (C) and
E. coli (D) isolates was measured following infection of HeLa cells left
untreated (dark blue), BL21-MAM7 treated (cyan) or treated with bead-
immobilized MAM7 (mid-blue). Values given are means ± standard error
(n = 3) from a representative experiment performed in triplicate.
Data points marked by an arrow were chosen for visualization using
confocal microscopy (Fig. 4). Inhibition data was analyzed for statistical
significance using a two-tailed t-test. Levels of significance were
indicated as extremely significant (***, p , 0.001), very significant
(**, p between 0.001–0.01), significant (*, p between 0.01–0.05) or not
significant (ns, p . 0.05).
Figure 3. Anti-adhesion treatment of 3T3 cells infected with bacterial
isolates. Cytotoxocity of ABC (A), P. aeruginosa (B), K. pneumoniae (C) and
E. coli (D) isolates was measured following infection of 3T3 cells left
untreated (dark red), BL21-MAM7 treated (red) or treated with bead-
immobilized MAM7 (orange). Values given are means ± standard error
(n = 3) from a representative experiment performed in triplicate.
Data points marked by an arrow were chosen for visualization using
confocal microscopy (Fig. 5). Inhibition data was analyzed for statistical
significance using a two-tailed t-test. Levels of significance were
indicated as extremely significant (***, p , 0.001), very significant
(**, p between 0.001–0.01), significant (*, p between 0.01–0.05) or not
significant (ns, p . 0.05).
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Figure 4. Visualization of anti-adhesion treatment of HeLa cells for representative examples from each group of bacterial isolate. HeLa cells were either
left untreated (top row), pre-incubated with BL21-MAM7 (middle row) or pre-treated with bead-immobilized MAM7 (bottom row). Cells were then left
uninfected (controls) (A, G and M) or infected with ABC isolate #1 (B, H and N), P. aeruginosa isolate #1 (C, I and O), P. aeruginosa isolate #3 (D, J and P),
K. pneumoniae isolate #1 (E, K and Q) or E. coli isolate #5 (F, L and R) for 4 h. Cells were stained for actin (phalloidin-Alexa488, green) and DNA (Hoechst
stain). Fluorescent latex beads are shown in yellow. Scalebar, 20 mm.
Figure 5. Visualization of anti-adhesion treatment of 3T3 cells for representative examples from each group of bacterial isolate. 3T3 cells were either left
untreated (top row), pre-incubated with BL21-MAM7 (middle row) or pre-treated with bead-immobilized MAM7 (bottom row). Cells were then left
uninfected (controls) (A, G and M) or infected with ABC isolate #1 (B, H and N), P. aeruginosa isolate #1 (C, I and O), P. aeruginosa isolate #3 (D, J and P),
K. pneumoniae isolate #1 (E, K and Q) or E. coli isolate #5 (F, L and R) for four hours. Cells were stained for actin (phalloidin-Alexa488, green) and DNA
(Hoechst stain). Fluorescent latex beads are shown in yellow. Scalebar, 20 mm.
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It is evident that for many pathogens, close contact has to be
maintained with host cells in order to establish a successful
infection. Many virulence factors are either soluble, secreted
toxins, which directly bind and translocate across the host cell
plasma membrane or form pores in the plasma membrane. Both
these processes are concentration dependent and therefore require
close contact with host cells to avoid loss by diffusion.23-25 Other
important virulence factors are infected directly into the host cell’s
cytoplasm, either by type III, type IV or type VI secretion
machinery, which also requires the bacterium to attach to host
cells.26-28 For this reason, we analyzed the correlation between host
cell attachment and cytotoxicity across each group of pathogen.
We generally found a positive correlation between attachment
and cytotoxicity for ABC, P. aeruginosa and E. coli isolates.
Interestingly, P. aeruginosa isolates showed no significant
correlation between these two factors. One explanation for this
would be a higher potency of virulence mechanisms in some
P. aeruginosa strains compared with other pathogens or other
strains within the same species (and thus only limited need for
attachment to elucidate a high degree of cytotoxicity). In this
light, it would be interesting to explore if some of the isolates are
hypervirulent compared with others. Another explanation for the
atypical behavior of some P. aeruginosa isolates would be that they
use additional virulence mechanisms which do not strictly depend
on direct contact between bacteria and host cells, such as bacterial
outer membrane vesicles (OMVs) or toxins which are active even
at low concentrations (and thus depend less on close proximity
between bacteria and host cells).29 OMVs are shed by a wide
variety of bacterial species and can be enriched in certain bacterial
proteins.30-32 In some cases, this may be employed as a mechanism
of translocating virulence factors across the host membrane, my
means of vesicle/plasma membrane fusion and endocytosis of
bacterial components.33,34 We have tested all isolates for the
presence of hemolysins using blood agar plating assays (Table 1),
but failed to detect any hemolytic activity in any of the isolates.
However, this does not fully exclude the presence of toxins with
other functions and this option will be more thoroughly explored
in future studies.
Previously, we have shown that pre-treatment of host cells with
MAM7, either presented on the surface of non-pathogenic
bacteria or immobilized on polymer beads, markedly decreased
the effects of infection with gastro-intestinal pathogens, such as
V. cholera, V. parahemolyticus, Y. pseudotuberculosis and EPEC.9
We further showed that the mechanism of MAM7-based
attachment inhibition is likely to be competition for a limited
number of host cell receptors (sites rich in both phosphatidic acid
and fibronectin), rather than steric hindrance, since the number of
attached BL21-MAM7 or MAM7-beads plateaus above an MOI
of 20 and the MAM7 dose required to achieve inhibition can be
kept relatively low.9,10 Thus, we hypothesized that wound-
associated Gram-negative pathogens utilizing a MAM7 homolog
for host cell attachment, such as strains belonging to the species
analyzed in this study, might also be responsive to the same mode
of treatment and explored the potential of MAM7-based
inhibitors in anti-adhesion treatment of such infections. We
observed a significant decrease of cytotoxic effects on cultured
cells following pre-treatment with MAM7 across all five tested
species. Two isolates of P. aeruginosa (P. aeruginosa isolates #2
and 3) and one isolate of ESBL-producing E. coli (isolate #2),
however, showed very limited responses to MAM7-treatment.
Most prominently, the highly cytotoxic isolate P. aeruginosa #3
showed almost no response to MAM7 inhibition. Overall, we
noticed that isolates with weak or no correlation between
attachment and cytotoxicity were less responsive to treatment.
Given that MAM7 inhibits the attachment of bacteria to host
cells, it is conclusive that strains that display a high degree of
cytotoxicity even at comparably low levels of attachment, such as
P. aeruginosa #3, would be less susceptible to anti-adhesion
treatment.
It has been noted in the literature that a strain’s ability to form
biofilms can be a crucial parameter in determining its resistance
toward small-molecule antimicrobials. This is due to the special
architecture of biofilms, which are composed of a conglomerate of
bacteria embedded in a matrix of secreted bacterial molecules,
such as polysaccharides, proteins and DNA and form a diffusion
barrier limiting delivery of antimicrobials to the pathogen.39 We
tested whether the isolates’ ability to form a biofilm had any
influence on their susceptibility to MAM7-based treatment. No
significant correlation was found between the amount of biofilm
formed and the efficiency of MAM7-based inhibition of
cytotoxicity (Table 3). However, it would be interesting to
re-evaluate these findings if the use of MAM7-based inhibition
Table 3. Analysis of correlation between biofilm formation and MAM7-based inhibition
BL21-MAM7 Bead-MAM7
Species Correlation coefficient (r) Significance (p) Correlation coefficient (r) Significance (p)
ABC HeLa -0.329 0.589 -0.486 0.407
3T3 -0.274 0.655 0.530 0.358
P. aeruginosa HeLa -0.785 0.116 -0.903 0.357
3T3 -0.777 0.122 -0.615 0.270
K. pneumoniae HeLa -0.335 0.582 0.173 0.780
3T3 0.656 0.229 0.460 0.436
E. coli HeLa -0.180 0.772 0.120 0.847
3T3 0.221 0.721 0.205 0.742
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was extended from prophylactic treatment as presented here
(where the timeframe of the experiment is likely shorter than that
required to form biofilm), to a potential therapeutic use in the
future (where biofilm structure would likely be pre-formed prior
to treatment).
We conclude that anti-adhesion prophylaxis with MAM7-
based inhibitors shows promise in the fight against a number of
important wound-associated pathogens that might be hard to treat
with conventional small molecule antimicrobials. Thus, experi-
ments presented here, investigating the efficacy of MAM7-based
inhibition using tissue culture models of infection, should be
extended to include relevant animal models of infection in the
future, even though this is beyond the scope of the present study.
Furthermore, we will aim future studies at improving MAM7-
based inhibitors in terms of affinity and avidity, with the hope to
extend their application from prophylaxis to therapy. Most
importantly, we demonstrate that the correlation between two
important hallmarks of virulence that can easily be tested for in
tissue culture, attachment and cytotoxicity could serve as a useful
predictor for the success of MAM7-based inhibition against
bacterial infections, and potentially other molecules used in
prophylactic anti-adhesion treatment.
Materials and Methods
Bacterial strains—isolation and growth conditions. Bacterial
isolates were acquired from patients treated at the San Antonio
Military Medical Center within the period from 2006 to 2010.
Cultures were obtained from sites as indicated in Table 1 and
passed twice on blood agar plates at 35°C prior to biofilm, PFGE
and susceptibility experiments. All isolates were grown in LB or
LB agar or in DMEM at 37°C for attachment and infection
experiments, unless otherwise indicated.
Bacterial genotyping. Clonal relationships between bacterial
strains of each genus were assessed by PFGE according to the
FDA method “Procedure for PFGE of Gram-negative rods”
(Version 1, 10/30/2007) and as previously described using the
CHEF-DRIII system (Bio-Rad Laboratories).35 The endonuclease
ApaI was used for ABC PFGE, XbaI for K. pneumoniae and E. coli
PFGE, and SpeI was used for P. aeruginosa PFGE. Gel images
were analyzed using BioNumerics software (Applied Maths).
PFGE patterns were interpreted and grouped into pulsed-field
types (PFTs) using established criteria.36
Biofilm assays. Biofilm formation was examined by measuring
the ability of bacteria to adhere and accumulate biomass on the
bottom of sterile 96-well flat-bottom polystyrene plates. Briefly,
fresh bacterial suspensions were prepared in either TSB or LB
from overnight cultures and adjusted to an OD600 of 0.25–0.3
(approximately 3  108 CFU/mL). One hundred microliters
aliquots of bacterial suspension were inoculated into individual
wells of a 96-well flat-bottomed polystyrene plate and incubated
at 37°C for 48 h. Following incubation, plates were gently washed
with 1X phosphate buffered saline (PBS; pH 7.4) and stained
with 100 mL of 0.1% Crystal Violet (CV) for 30 min. Excess
crystal violet was removed by washing, and biofilm biomass was
quantified by measuring the corresponding optical density at
570 nm of the supernatant following the solubilization of CV
in 95% ethanol. For each strain tested, biofilm experiments
were performed in triplicate. Percentage of biofilm formation was
calculated as (OD570 sample/OD570control)*100. The control
strain used was Staphylococcus epidermidis ATCC 12228.
Hemolysis assays. To access production of hemolysins, strains
were grown in LB at 37°C overnight, streaked onto blood agar
plates containing 5% sheep erythrocytes and again grown
overnight at 37°C. Hemolysis was accessed visually (appearance
of zone of clearance around colonies).
Attachment assays. Bacterial attachment to host cells was
essentially tested for as previously described.9 Briefly, mammalian
cells were cultured in DMEM (Invitrogen) supplemented with
10% heat-inactivated fetal bovine serum (HeLa cells) or 10%
bovine calf serum (3T3 fibroblasts), 5 mM sodium pyruvate and
50 mg/mL penicillin and steptomycin at 37°C with 5% CO2.
Cells were washed with PBS (phosphate-buffered saline) prior to
the addition of bacteria in DMEM without antibiotics. Bacteria
were added to give a multiplicity of infection (MOI) of 10. To
determine the bacterial titer after incubation, bacteria were added
to empty wells. Plates were centrifuged (1000 g, 22°C, 5 min)
prior to incubation at 37°C for 1 h. Cells were washed three times
with PBS and lysed by adding 0.5% Triton X-100 in PBS. Input
samples and Triton lysates were mixed by pipetting up and down
several times, serially diluted, plated on LB agar and enumerated
by colony counting. Percentage attachment was determined as
(number of attached cells/bacterial titer after incubation)*100.
Lactate dehydrogenase (LDH) release assays. To measure
cytotoxicity, tissue culture cells were washed with PBS prior to the
addition of bacteria in DMEM without antibiotics at an MOI of
10. Infections were started by centrifugation of plates (1000 g,
22°C, 5 min) prior to incubation at 37°C. Two hundred
microliters of supernatant was removed in triplicate from each
well four hours after infection, centrifuged (1000 g, 22°C,
5 min), and 100 ml of the supernatant transferred to a fresh 96-
well plate for assays. To quantitate cell lysis, the amount of lactate
dehydrogenase (LDH) released into the culture medium was
measured colorimetrically using the LDH cytotoxicity detection
kit (Takara) according to the manufacturer’s protocol. Percent-
age cell lysis was calculated as [(Ainfected cells-Auntreated cells)/
(ATriton-lysed cells-Auntreated cells)]*100.
Antimicrobial susceptibility testing. Antibiotic susceptibility
testing was performed using the BD PhoenixTM Automated
Microbiology System (Becton Dickinson) according to the manufac-
ture’s guidelines. Results are accessed through the EpiCenter
Database (Becton Dickinson) connected to the Phoenix system.
MAM7-inhibition experiments. For inhibition experiments,
tissue culture cells were pre-incubated with either E. coli BL21
expressing V. parahemolyticus MAM7 (MOI of 100) or
recombinant, bead-immobilized MAM7 for 30 min as described
previously.9,11 Generation of BL21-MAM7, cloning of expression
constructs for GST and GST-MAM7 fusion protein and protein
purifications have been described elsewhere.9,10 Purified proteins
were immobilized on 1 mm fluorescent orange latex beads (Sigma)
as described by El Shazly et al.37 For inhibition experiments, a
total of 7.5 mg protein/106 beads/well in PBS was used. After
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removing excess bacteria or beads by three PBS washes, cultured
cells were infected with clinical isolates for four hours and
cytotoxicity measured as described above for LDH release assays.
Fluorescence microscopy. Cells were seeded onto coverslips at
150,000 cells/mL and subjected to infection experiments the next
day. Following infection experiments, cells were washed with PBS
and fixed with 3.2% paraformaldehyde in PBS for 15 min. Fixed
cells were permeabilized with 0.1% Triton X-100 in PBS for
5 min and treated with Hoechst (Sigma) and Alexa Fluor 488-
phalloidin (Molecular Probes) for 10 min to stain for DNA and
F-actin, respectively. Coverslips were mounted onto 10% (w/v)
glycerol and 0.7% (w/v) propyl gallate in PBS, sealed with nail
polish and viewed using a Zeiss LSM510 META Laser Scanning
Confocal Microscope. Images were processed using ImageJ and
Photoshop software.
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